These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9186455)

  • 1. New treatment approach for high blood pressure patients defined as cardioprotective by physicians.
    S Afr Med J; 1997 Feb; 87 Suppl 1():C60. PubMed ID: 9186455
    [No Abstract]   [Full Text] [Related]  

  • 2. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):771-5. PubMed ID: 15350178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW
    South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent clinical trials in hypertensiology].
    Kurlapska E; Goch JH; Kasprzak K; Goch A
    Pol Merkur Lekarski; 2010 Jun; 28(168):473-7. PubMed ID: 20642108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations.
    Ruilope LM; Segura J
    Expert Opin Pharmacother; 2010 Nov; 11(16):2619-23. PubMed ID: 20977398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ANBP-2].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():414-8. PubMed ID: 16981572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current features of antihypertensive drug treatment].
    Luño J; García de Vinuesa S
    Rev Clin Esp; 1999 Dec; 199(12):834-9. PubMed ID: 10687418
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PROGRESS].
    Hasegawa Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
    [No Abstract]   [Full Text] [Related]  

  • 12. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of treatment of hypertension on cardiovascular outcome in type 2 diabetes.
    Migdalis IN
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):105-14. PubMed ID: 17974100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension in the elderly].
    Ogihara T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():394-8. PubMed ID: 15171406
    [No Abstract]   [Full Text] [Related]  

  • 15. Who is fooling us?
    Sleight P; Yusuf S
    Lancet; 2002 Sep; 360(9336):873-4. PubMed ID: 12243941
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.
    Ferrari R; Boersma E
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):705-17. PubMed ID: 23750680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 18. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Mancia G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-3. PubMed ID: 1725194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.